Jacobs Levy Equity Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.27M | Sell |
261,626
-39,098
| -13% | -$1.24M | 0.03% | 337 |
|
|
2025
Q1 | $9.98M | Sell |
300,724
-12,289
| -4% | -$408K | 0.04% | 339 |
|
|
2024
Q4 | $10.8M | Buy |
313,013
+88,532
| +39% | +$3.05M | 0.04% | 293 |
|
|
2024
Q3 | $8.98M | Sell |
224,481
-20,845
| -8% | -$834K | 0.03% | 341 |
|
|
2024
Q2 | $7.4M | Buy |
245,326
+7,999
| +3% | +$241K | 0.03% | 381 |
|
|
2024
Q1 | $7.97M | Sell |
237,327
-1,408
| -0.6% | -$47.3K | 0.04% | 338 |
|
|
2023
Q4 | $7.71M | Buy |
238,735
+3,847
| +2% | +$124K | 0.04% | 345 |
|
|
2023
Q3 | $7.7M | Sell |
234,888
-51,136
| -18% | -$1.68M | 0.05% | 299 |
|
|
2023
Q2 | $10.1M | Sell |
286,024
-90,362
| -24% | -$3.18M | 0.06% | 279 |
|
|
2023
Q1 | $12.3M | Sell |
376,386
-2,641
| -0.7% | -$86.2K | 0.08% | 256 |
|
|
2022
Q4 | $20.9M | Sell |
379,027
-42,138
| -10% | -$2.32M | 0.14% | 185 |
|
|
2022
Q3 | $18.7M | Buy |
+421,165
| New | +$18.7M | 0.15% | 177 |
|